Prometheus Laboratories

San Diego, United States Founded: 1995 • Age: 31 yrs Acquired By Nestlé Health Science
Diagnostics and therapeutics for gastrointestinal and personalized medicine are developed.
Annual revenue - Latest available
Total funding - 3 rounds
Employees 474 Tracked headcount
Investors 3 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Prometheus Laboratories

Prometheus Laboratories is a company based in San Diego (United States) founded in 1995 was acquired by Nestlé Health Science in May 2011. The company has 474 employees as of December 31, 2022. Prometheus Laboratories offers products and services including Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus. Prometheus Laboratories operates in a competitive market with competitors including Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals, Given Imaging and EnteraSense, among others.

  • Headquarter San Diego, United States
  • Employees 474 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Prometheus Laboratories Inc
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $260 M (USD), Debt – Conventional

    Jan 07, 2010

  • Investors
  • Employee Count
    474

    as on Dec 31, 2022

  • Acquired by
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Prometheus Laboratories

Prometheus Laboratories offers a comprehensive portfolio of products and services, including Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus.

Product name locked
Category locked
Primary

Monitors infliximab levels for effective IBD treatment management.

Product name locked
Category locked
Locked

Assesses adalimumab levels in patients with gastrointestinal conditions.

Product name locked
Category locked
Locked

Evaluates disease activity for inflammatory bowel disease monitoring.

Product name locked
Category locked
Locked

Detects celiac disease through genetic and serological analysis.

People of Prometheus Laboratories

Headcount 50-200
Employee Profiles 55
Board Members and Advisors 6
Employee Profiles
People
Thierry Dervieux
Chief Scientific Officer
People
Duane Shine
Processing Manager
People
Lei Lu
SVP, Finance & Accounting
People
Alison Burke
Executive Sales Specialist

Unlock access to complete

Board Members and Advisors
people
Mark McKenna
Executive Chairman
people
Dermot McGovern
Scientific Advisor
people
Adam Cheifetz
Scientific Advisor
people
Martin Hendrix
Director

Unlock access to complete

Funding Insights of Prometheus Laboratories

Investors in Prometheus Laboratories

Prometheus Laboratories has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Nestlé Health Science, Pamlico Capital and National Science Foundation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Pamlico Capital is engaged in private equity investments for growth companies.
Locked Locked Locked
A government-backed foundation providing seed-stage investments to support small businesses.
Locked Locked Locked
Nutritional dietary supplements are provided for health and wellness needs.
Locked Locked Locked
Premium access

Investor details for Prometheus Laboratories

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Prometheus Laboratories

Investments
Premium access

Investment portfolio details for Prometheus Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Prometheus Laboratories

Premium access

Detailed financials for Prometheus Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Prometheus Laboratories Comparisons

Prometheus Laboratories Primary company
Description
Diagnostics and therapeutics for gastrointestinal and person...
Location
San Diego, United States
Founded Year
1995
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
474
As of 2022
Premium access

Peer comparison for Prometheus Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Prometheus Laboratories

Prometheus Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome Life Sciences, NinePoint Medical, InDex Pharmaceuticals, Given Imaging and EnteraSense, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of tests to prevent, treat, and cure chronic diseases, and cancer
Locked Locked Locked
Optical coherence tomography systems for tissue microstructure imaging are developed.
Locked Locked Locked
DNA-based immunomodulatory drugs for ulcerative colitis are developed.
Locked Locked Locked
Capsule endoscopy systems for GI imaging
Locked Locked Locked
Ingestible biosensor for GI disease
Premium access

Detailed competitors of Prometheus Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Prometheus Laboratories

Premium access

Complete news archive for Prometheus Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prometheus Laboratories

Prometheus Laboratories was founded in 1995 and raised its 1st funding round 4 years after it was founded.

Prometheus Laboratories is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Joseph Limber is the current CEO of Prometheus Laboratories.

As of Dec 31, 2022, the latest employee count at Prometheus Laboratories is 474.

Prometheus Laboratories develops diagnostics for the gastrointestinal space. As of Jan 2016, it offers diagnostics for patient responsiveness to infliximab and adalimumab, irritable bowel syndrome, celiac disease, thipurine metabolite and liver fibrosis in Hep C patients, and prognostics for Crohns disease. In addition, the company also provides genetic tests for lactose intolerance and a therapeutic product proleukin for metastatic melanoma and kidney cancer. In May 2011, Prometheus became a subsidiary of Nestlé Health Science.

Prometheus Laboratories's top competitors include Viome Life Sciences, NinePoint Medical and InDex Pharmaceuticals.

Prometheus Laboratories offers Anser IFX, Anser ADA, Monitr IBD, and Celiac Plus.

Prometheus Laboratories has 3 investors. Key investors include Nestlé Health Science, Pamlico Capital, and National Science Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available